Protara Therapeutics (TARA) EPS (Basic) (2013 - 2026)
Protara Therapeutics (TARA) posted quarterly EPS (Basic) of -$0.5 for Q1 2026, down 12.06% year-over-year from -$0.57 in Q1 2025, and down 10.49% quarter-over-quarter from -$0.45 in Q4 2025.
Powered by 
Analysis
Protara Therapeutics (TARA) EPS (Basic) (2013 - 2026) Analysis & Trends
Protara Therapeutics (TARA) has reported EPS (Basic) for 14 consecutive years, with -$0.5 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 12.06% year-over-year to -$0.5; the TTM figure through Mar 2026 stood at -$1.54 (down 7.76% YoY), while the FY2025 annual figure was -$3.46, up 39.85% from the prior year.
- EPS (Basic) fell to -$0.5 in Q1 2026 per TARA's latest filing, from -$0.45 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.96 in Q1 2022 and bottomed at -$3.46 in Q4 2022.
- Historically, EPS (Basic) has averaged -$0.88 across 5 years, with a median of -$0.55 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 178.09% — and 2024, when it slumped 269.15%.
- Protara Therapeutics' EPS (Basic) stood at -$3.46 in 2022, then jumped by 73.94% to -$0.9 in 2023, then soared by 38.75% to -$0.55 in 2024, then increased by 17.66% to -$0.45 in 2025, then dropped by 10.49% to -$0.5 in 2026.
- Business Quant data shows TARA's EPS (Basic) at -$0.5 in Q1 2026, -$0.45 in Q4 2025, and -$0.46 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - | -0.36 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36 |
| Mar 31, 2026 | -0.31 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -0.45 |
| Mar 31, 2024 | -0.97 |
| Dec 31, 2023 | -0.90 |
| Sep 30, 2023 | -0.87 |
| Jun 30, 2023 | -2.60 |
| Mar 31, 2023 | 0.80 |
| Dec 31, 2022 | -3.46 |
| Sep 30, 2022 | -0.68 |
| Jun 30, 2022 | -2.67 |
| Mar 31, 2022 | 0.96 |
| Dec 31, 2021 | -0.91 |
| Sep 30, 2021 | -0.96 |